Search results
PTC Therapeutics Stock Soars As Its Biggest Drug 'Lives To Fight Another Day'
Investor's Business Daily· 6 hours agoPTC stock hit a nine-month high Monday after the European Commission decided against pulling its...
EC withholds negative stance on Translarna in Europe By Investing.com
Investing.com· 11 hours agoPTC Therapeutics, Inc. (NASDAQ: NASDAQ:PTCT) disclosed on Monday that the European Commission (EC)...
Kentucky Retirement Systems Insurance Trust Fund Reduces Holdings in PTC Inc. (NASDAQ:PTC)
ETF DAILY NEWS· 15 hours agoKentucky Retirement Systems Insurance Trust Fund reduced its holdings in shares of PTC Inc. (NASDAQ:PTC – Free Report) by 4.8% in the fourth quarter, according ...
PTC Therapeutics stock target raised on re-evaluation of Translarna By Investing.com
Investing.com· 9 hours agoOn Monday, Jefferies maintained a Buy rating on PTC Therapeutics (NASDAQ:PTCT) and increased the...
PTC Therapeutics (NASDAQ:PTCT) Upgraded at Raymond James
ETF DAILY NEWS· 17 hours agoPTC Therapeutics (NASDAQ:PTCT – Get Free Report) was upgraded by Raymond James from an “underperform” rating to a “market perform” rating in a research report issued on Monday ...
PTCT stock target raised, maintains sell rating on favorable regulatory development By Investing.com
Investing.com· 7 hours agoOn Monday, Goldman Sachs updated its view on PTC Therapeutics shares (NASDAQ:PTCT), raising the...
Exploring Top Dividend Stocks In India For May 2024
Simply Wall St. via Yahoo Finance· 50 minutes agoThe Indian market has shown remarkable growth, surging 46% over the past year and gaining 3.8% in just the last week, with earnings expected to grow by...
European Commission, in ‘unprecedented’ move, declines to revoke approval of PTC Duchenne drug
BioPharma Dive via Yahoo Finance· 14 hours agoRather than endorse the recommendation of the EMA, the commission called for a new review for...
PTC Therapeutics Pauses 2024 Revenue Guidance After European Commission Requests Reevaluation of...
Market Watch· 14 hours agoPTC Therapeutics has paused its 2024 revenue guidance after the European Commission decided against adopting a committee's negative opinion on the annual renewal of Translarna's ...
PTC stock rated an Overweight by JP Morgan – Knox Daily
Knox Daily· 7 days agoPTC Inc’s recently made public that its Director Lathan Corinna unloaded Company’s shares for reported $0.34 million on May 09 ’24. In the deal valued at $179.39 per share ...